Rothschild's exit

OXFORD - Rothschild Asset Management has decided to pull out of biotech investing, pulling the rug from under the proposed merger of Biotechnology Investments Ltd. (LSE:BIL) and the International Biotechnology Trust (LSE:IBT).

IBT Chairman Jock Green-Armytage told BioCentury that the IBT board is close to announcing the new manager of the trust, which focuses its investments on late stage and publicly traded companies. To ensure

Read the full 649 word article

How to gain access

Continue reading with a
two-week free trial.